WFLA News Channel 8: Diagonal Therapeutics to Present New Preclinical Data Demonstrating Disease-Modifying Potential of Receptor Clustering Antibody Approach in HHT at EHA 2025 Congress Results demonstrate potential of Company’s clustering antibody approach to address key challenges in HHT disease manifestations: restoring ALK1-mediated cellular signaling, preventing and reversing ... Diagonal Therapeutics to Present New Preclinical Data Demonstrating Disease-Modifying Potential of Receptor Clustering Antibody Approach in HHT at EHA 2025 Congress Hereditary hemorrhagic telangiectasia (HHT) is an inherited disorder that affects the blood vessels. A person with HHT may have blood vessels that have not developed properly and may have no ...

Understanding the Context

GEN: Rare Bleeding Disorder, HHT, Treated Successfully with Cancer Drug in Clinical Trial Rare Bleeding Disorder, HHT, Treated Successfully with Cancer Drug in Clinical Trial The Columbus Dispatch: National CHORUS Study Brings New Visibility to the Full Impact of HHT, Urgency of HHT Diagnosis New CHORUS data published in Blood show HHT is a serious multisystem bleeding disorder requiring earlier diagnosis, ...